Summary
- Current Price
- As of today, GRCE price is $4.40, down -0.90% in the most recent trading session on
- Current Price All-Time High
- GRCE price is currently -99.78% below its historical high of $2,016.00 set on
- Market Cap
- GRCE current market cap is $67M, up +90.86% over the past 365 days
- PE Ratio
- GRCE PE ratio is unknown
- Revenue
- GRCE current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for GRCE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Grace Therapeutics, Inc. |
| Ticker | NASDAQ: GRCE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | gracetx.com |
| Employees | 6 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.40 | ||
| Price, 1D Change | -0.90% | |
| $67M | ||
| - | ||
| - | ||
| 0.85 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.79 | ||
| EPS, 1Y Change | +41.31% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:6 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ACST | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.79 | ||
| EPS Estimate | N/A | -$1.16 |
| EPS Est. Change | N/A | -45.91% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $4.40 | ||
| Price Target | - | $11.45 |
| Price Tgt. Change | - | +160.28% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.66 | -$0.79 | +52.24% | |
| -$1.16 | N/A | -45.91% | |
| -$0.88 | N/A | -11.29% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| $11.69M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +72.55% | ||
| +66.67% | ||
| +90.86% | ||
| +240.13% | ||
| 0.00% | ||
| 0.00% | ||
| +41.31% | ||
| +50.50% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $4.40 | ||
| $3.31 | ||
| SMA 200 vs Price | -24.84% | |
| $3.83 | ||
| SMA 50 vs Price | -12.98% | |
| 0.85 | ||
| $0.29 | ||
| 68.93 | ||
| 36.08% | ||
| 49.56% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.79 | ||
| -$7,000.00 | ||
| - | ||
| -$16.68M | ||
| - | ||
| -$9.57M | ||
| - | ||
| -$16.67M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 11.77 | ||
| 11.77 | ||
| - | ||
| - | ||
| -1.44 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.03 | ||
| -4.28 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $66.61M | ||
| $22.13M | ||
| $81.24M | ||
| $22.71M | ||
| $14.63M | ||
| $1.93M | ||
| $0.00 | ||
| $0.00 | ||
| $601.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $9.57M | ||
| $16.67M | ||
| $7,000.00 | ||
| $0.00 | ||
| $7,000.00 | ||
| $0.00 | ||
| -$3.20M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$14.90M | ||
| $0.00 | ||
| $14.03M | ||
| $0.00 | ||
| -$14.90M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with GRCE
FAQ
What is the ticker symbol for Grace Therapeutics, Inc.?
The ticker symbol for Grace Therapeutics, Inc. is NASDAQ:GRCE
Does Grace Therapeutics, Inc. pay dividends?
No, Grace Therapeutics, Inc. does not pay dividends
What sector is Grace Therapeutics, Inc. in?
Grace Therapeutics, Inc. is in the Healthcare sector
What industry is Grace Therapeutics, Inc. in?
Grace Therapeutics, Inc. is in the Biotechnology industry
What country is Grace Therapeutics, Inc. based in?
Grace Therapeutics, Inc. is headquartered in United States
When did Grace Therapeutics, Inc. go public?
Grace Therapeutics, Inc. initial public offering (IPO) was on February 7, 2012
Is Grace Therapeutics, Inc. in the S&P 500?
No, Grace Therapeutics, Inc. is not included in the S&P 500 index
Is Grace Therapeutics, Inc. in the NASDAQ 100?
No, Grace Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Grace Therapeutics, Inc. in the Dow Jones?
No, Grace Therapeutics, Inc. is not included in the Dow Jones index
When was Grace Therapeutics, Inc. last earnings report?
Grace Therapeutics, Inc.'s most recent earnings report was on June 20, 2025
When does Grace Therapeutics, Inc. report earnings?
The date for Grace Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- GRCE Official Website www.gracetx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1444192/000114036125023259/0001140361-25-023259-index.htm
- GRCE Profile on Yahoo Finance finance.yahoo.com/quote/GRCE
- GRCE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grce